Related Experiment Video
Updated: Jun 27, 2026

Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration
Published on: May 26, 2023
[Familial exudative vitreoretinopathy: our experience]
A M Piñero1, J Sempere, J Nadal
1Instituto Universitario Barraquer, Barcelona, Spain. anapinero@co-barraquer.es
Purpose:
To describe our experience in the diagnosis of Familial Exudative Vitreoretinopathy (FEVR) at its different clinical stages. We also report our outcomes in early treatment of this inherited disorder.
Methods:
Retrospective interventional and descriptive case series of 11 patients (17 eyes) affected by FEVR evaluated and treated in our hospital.
Results:
In our series, 33.3% of patients were classified as stage I, while 16.7% and 50% were classified as stage II and III, respectively. Visual acuity (VA) remained stable after treatment in stages I and II (mean VA was 0.8 and 0.4, respectively) but decreased in stage III.
Conclusions:
Early treatment of FERV may improve the visual prognosis and avoid complications such as subfoveal chronic exudation and vitreoretinal peripheral interphase contraction and fibrosis.
Related Concept Videos
Diabetic Retinopathy
Glaucoma: Overview
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment

